These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16336003)

  • 1. Using bioinformatics for drug target identification from the genome.
    Jiang Z; Zhou Y
    Am J Pharmacogenomics; 2005; 5(6):387-96. PubMed ID: 16336003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting drug-target interactions from chemical and genomic kernels using Bayesian matrix factorization.
    Gönen M
    Bioinformatics; 2012 Sep; 28(18):2304-10. PubMed ID: 22730431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative Analysis of Genetic, Genomic, and Phenotypic Data for Ethanol Behaviors: A Network-Based Pipeline for Identifying Mechanisms and Potential Drug Targets.
    Bogenpohl JW; Mignogna KM; Smith ML; Miles MF
    Methods Mol Biol; 2017; 1488():531-549. PubMed ID: 27933543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomics approaches to drug discovery.
    Reidhaar-Olson JF; Rhees BK; Hammer J
    J Cell Biochem Suppl; 2001; Suppl 37():110-9. PubMed ID: 11842436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
    Phan JH; Quo CF; Wang MD
    Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding nuclear receptors using computational methods.
    Ai N; Krasowski MD; Welsh WJ; Ekins S
    Drug Discov Today; 2009 May; 14(9-10):486-94. PubMed ID: 19429508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-target interaction prediction by random walk on the heterogeneous network.
    Chen X; Liu MX; Yan GY
    Mol Biosyst; 2012 Jul; 8(7):1970-8. PubMed ID: 22538619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targetability of human disease genes.
    Sakharkar MK; Sakharkar KR
    Curr Drug Discov Technol; 2007 Jun; 4(1):48-58. PubMed ID: 17630928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Druggability of human disease genes.
    Sakharkar MK; Sakharkar KR; Pervaiz S
    Int J Biochem Cell Biol; 2007; 39(6):1156-64. PubMed ID: 17446117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using silico methods predicting ligands for orphan GPCRs.
    Jiang Z; Zhou Y
    Curr Protein Pept Sci; 2006 Oct; 7(5):459-64. PubMed ID: 17073696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IUPHAR-DB: updated database content and new features.
    Sharman JL; Benson HE; Pawson AJ; Lukito V; Mpamhanga CP; Bombail V; Davenport AP; Peters JA; Spedding M; Harmar AJ;
    Nucleic Acids Res; 2013 Jan; 41(Database issue):D1083-8. PubMed ID: 23087376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging techniques for the discovery and validation of therapeutic targets for skeletal diseases.
    Cho CH; Nuttall ME
    Expert Opin Ther Targets; 2002 Dec; 6(6):679-89. PubMed ID: 12472380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A chemogenomic approach to drug discovery: focus on cardiovascular diseases.
    Cases M; Mestres J
    Drug Discov Today; 2009 May; 14(9-10):479-85. PubMed ID: 19429507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current bioinformatics tools in genomic biomedical research (Review).
    Teufel A; Krupp M; Weinmann A; Galle PR
    Int J Mol Med; 2006 Jun; 17(6):967-73. PubMed ID: 16685403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fulfilling the promise: drug discovery in the post-genomic era.
    Chanda SK; Caldwell JS
    Drug Discov Today; 2003 Feb; 8(4):168-74. PubMed ID: 12581711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using bioinformatics and genome analysis for new therapeutic interventions.
    Mount DW; Pandey R
    Mol Cancer Ther; 2005 Oct; 4(10):1636-43. PubMed ID: 16227414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying targets for drug discovery using bioinformatics.
    Chen YP; Chen F
    Expert Opin Ther Targets; 2008 Apr; 12(4):383-9. PubMed ID: 18348676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target validation and drug discovery using genomic and protein-protein interaction technologies.
    Pillutla RC; Fisher PB; Blume AJ; Goldstein NI
    Expert Opin Ther Targets; 2002 Aug; 6(4):517-31. PubMed ID: 12223066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A survey on the computational approaches to identify drug targets in the postgenomic era.
    Dai YF; Zhao XM
    Biomed Res Int; 2015; 2015():239654. PubMed ID: 26060814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.